news
Sabinsa CEO on innovation, quality, and beet extract for menopause
Sabinsa CEO Shaheen Majeed discussed the company's commitment to ingredient quality and innovation, highlighting new research on beet extract for postmenopausal women. The study revealed benefits for cardiovascular health and inflammation in this demographic. This signals an increased focus on targeted natural solutions for menopausal symptoms.
Sabinsa CEO Shaheen Majeed discussed the company's commitment to ingredient quality and innovation, highlighting new research on beet extract for postmenopausal women. The study revealed benefits for cardiovascular health and inflammation in this demographic. This signals an increased focus on targeted natural solutions for menopausal symptoms.
The architecture take
Listen, 'quality first' should always be the baseline for supplement ingredients, not a talking point. What's actually interesting here is the spotlight on beet extract for postmenopausal women. Most people know beets for nitric oxide and athletic performance, but this pushes it into hormone health and inflammation. It's a smart play, because while the GLP-1 craze is huge, the real money long-term is in condition-specific nutrition that tackles things like post-menopause inflammation and cardiovascular markers. Look at the data, not the marketing copy: if beet extract can genuinely move the needle on those, expect more ingredient suppliers and brands to start digging into natural compounds for specific health stages. This isn't just about 'clean label' anymore; it's about efficacy and measurable impact for neglected demographics. Smart move by Sabinsa to get ahead of the curve here.